KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced new data from its sebetralstat clinical trial program presented ...
Octave, the potential software spin-off from Hexagon AB, today unveiled its new brand identity, marking a major step toward ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results